Systemic adjuvant therapy women resected node-negative breast cancer role adjuvant systemic therapy women node-negative breast cancer Several studies adjuvant hormonal therapy adjuvant chemotherapy moderate reduction risk recurrence treated patients limited follow-up overall survival use adjuvant therapy use prognostic factors patients risk relapse active area oncologic research decision adjuvant therapy assessment probability recurrence expected reduction risk adjuvant therapy toxic effects therapy influence treatment patient overall quality life 